Navigation Links
Acuo Technologies Announces Vendor Neutral Archiving Contract With Children's Hospital of Philadelphia
Date:11/30/2008

ST. PAUL, Minn., Nov. 30 /PRNewswire/ -- Acuo Technologies(R), developers of high-performance software for intelligent medical image management, data migration tools and services, contracting with Children's Hospital of Philadelphia for a new archiving solution which becomes the basis of the Hospital's medical image management platform.

Financial terms of the deal were not disclosed.

This integrated medical imaging solution allows the Children's Hospital of Philadelphia (CHOP) to gain control of more than 60 terabytes of medical data such as x-rays, cardiology images and pathology slides, giving the hospital an automated solution that will provide business continuity and result in a lower total cost of ownership.

The solution selected by CHOP is designed to allow all medical images to be stored on CHOP's infrastructure, allowing the hospital's Electronic Medical Record (EMR) portal to have one location to retrieve patient images, instead of multiple integrations and locations. The combined solution will also ensure that all patient studies are safely stored, protected and can be accessed from any CHOP location in a consistent and reliable fashion.

Children's Hospital of Philadelphia will be using the Acuo DICOM Assisted Migration (ADAM) to move data from the existing proprietary archive into the Acuo vendor neutral archive, ensuring that CHOP will be able to gain control of their data and never pay for a migration again. The Acuo solution will also be used as an intelligent routing destination for all radiology modalities providing high availability using Virtual IP technology from Cisco's ACE product line.

"We are extremely pleased to consummate this new relationship with one of the most prestigious Children's Hospital's in the world today," states Jeff Timbrook, CEO of Acuo Technologies. "The lifecycle of clinical content for Children's Hospitals is significantly long
'/>"/>

SOURCE Acuo Technologies
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Patient Safety Technologies Reports Third Quarter 2008 Results
2. Varian Medical Systems to Exhibit the Latest X-Ray Image Detectors, X-Ray Tubes, and Cancer Treatment Technologies at RSNA This Year
3. Gulf Coast Hospital Chooses Global Med Technologies(R) Blood System
4. AETEA Acquires ecipient Technologies
5. Cognitive Technologies Supports PMO for APS Healthcare
6. Wound Management Technologies, Inc. Announces FDA Clearance of 510k
7. Netsmart Technologies Releases Version 7.5 Of Helper™ Practice Management Software
8. Netsmart Technologies Releases Version 7.5 of Helper(TM) Practice Management Software
9. VNUS Medical Technologies to Present at Lazard Capital Markets 5th Annual Healthcare Conference
10. Advanced Imaging Technologies to Limit Breast and GI Biopsy Procedures
11. Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...lif. The newest revolution in microbiology testing...air sheep, a less-hirsute version of the familiar ...nford University School of Medicine, which is to b...nly are these ruminants low-maintenance and parasi...r the microbiology tests necessary to diagnose inf...
(Date:7/3/2009)... through divorce or death in middle age may triple...y 2 (HealthDay News) -- Middle-aged adults who liv... Alzheimer,s disease later in life compared to tho... risk is three times higher among those who are di...dish and Finnish researchers. , The study inclu...
(Date:7/3/2009)... Eva,s Village, ( http://www.EvasVillage....ty, Seeks Buyers for 35mm Michael Jackson Film Pri... Paterson, NJ (PRWEB) July 3, 2009...a non-profit New Jersey anti-poverty charity, seek...int of Michael Jackson,s "Thriller" musi...
(Date:7/3/2009)... Julian Whitaker, MD, a founder of the al...t on searchjointpain.com, a new informational Web ...nditions and solutions. , ...er, MD, a founder of the alternative health moveme...m, a new informational Web site devoted to all asp...
Breaking Medicine News(10 mins):Health News:Rare sheep could be key to better diagnostic tests in developing world, says Stanford study 2Health News:Rare sheep could be key to better diagnostic tests in developing world, says Stanford study 3Health News:Living Alone Increases Odds of Developing Dementia 2Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 2Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 3Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 4Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 5Health News:Dr. Julian Whitaker Featured on Searchjointpain.com 2
...hurch of England plans to enter into partnership w...ng to people moving into new homes. // The vicar ...ocese whose special prayers are intended to cover ...Rev Chris Painter, a vicar in Eccles, Greater Manc...
...ndian Institute of Technology (IIT-K) and the Gane...ge have entered into an agreement to carry out joi...echnology that would be of wider interest to all s...have signed a memorandum of understanding (MoU) in...
..., the African leader set new targets to the govern...d this in the Nigerian capital. a major resolution... patients suffering from these diseases should hav...iral (ARV) drugs, care and support. Civil society ...
...ding to the survey conducted among the doctors of ...they were against the proposed legislation of Euth...rs were against this law. Lord Joffe's issued a bi...ctors should be given rights to prescribe drugs th...
Other Medicine News:Health News:New Home New Blessings 2
(Date:6/29/2009)...ire/ -- Vantia Therapeutics, an,emerging pharmace...ugs,targeting large, underserved medical markets,...ical trial of its lead development compound VA1064...483 was successful in producing a,predictable and...termined by,increased osmolality and decreased ur...
(Date:6/28/2009)...29 Data presented,today, in Budap...ovel,once-daily anti-epileptic Zebinix(R)* (esli...d sustained decrease in seizure frequency over the...extension of a pivotal Eslicarbazepine Acetate,ph...Congress for Epilepsy in,Budapest, Hungary. Patie...
(Date:6/26/2009)..., June 27, 2009 Takeda Pharmaceuti...t Takeda Global Research & Development Center,...ary received on June 26 (U.S. time) a complete res...ation (FDA) regarding the Company,s New Drug Appli...l peptidase IV (DPP-4) inhibitor under investigati...
(Date:6/26/2009)... Cancer Recurrence Test MammaPrint,Included in In...tions" issued,on 23 Jun 2009 12:00 GMT, by Agendi...he subheadline was missing from the release as inc...rrected release follows: , , /PRNewswire...est MammaPrint Included in,International St. Gall...
Breaking Medicine Technology:Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 2Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 5Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 6Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 7Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes 2/C O R R E C T I O N -- Agendia B.V./ 2/C O R R E C T I O N -- Agendia B.V./ 3Life Brokerage Partners Adds New Insurance Carriers 9437 1Life Brokerage Partners Adds New Insurance Carriers 9437 2Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance 28TM 29 9434 1Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance 28TM 29 9434 2Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance 28TM 29 9434 3Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance 28TM 29 9434 4Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance 28TM 29 9434 5Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance 28TM 29 9434 6Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance 28TM 29 9434 7UM Sylvester Offers Community the Gift of Well Being 9432 1UM Sylvester Offers Community the Gift of Well Being 9432 2UM Sylvester Offers Community the Gift of Well Being 9432 3Personal Safes Market to Top 24308 Million by 2011 1854 1Personal Safes Market to Top 24308 Million by 2011 1854 2
... 2007 /PRNewswire-FirstCall/ --,Advanced Magnetics...ase III multi- center clinical studies of ferumoxy... will be presented during,the National Kidney Foun...place April 10th through 14th in Orlando, Florida....be presented on,Wednesday, April 11, 2007 at appro...
...wed Complete Response or Reduction of,Lesion Size ... 05, 2007 /PRNewswire-FirstCall/ - Nventa,Biopharm...ation of,positive results from a clinical trial ex...spE7, an investigational therapeutic,vaccine for h...en,with the highest grade of cervical dysplasia (C...
Other Medicine Technology:Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 2Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 3Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 4Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 2Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 3Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 4Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 5Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 6
The ICP-Monitor for intraventricular, intraparenchymal and epidural measurement of intracranial pressure and for measuring cerebral perfusion pressure and compliance.
The MPM-1 offers a broad range of functions to attain new levels of parenchymal and ventricular monitoring through fiberoptic technology at the source.
The IVR-Optical Tracking system is engineered for easy calibration. This procedure can be done within five minutes by trained personnel, and is the only calibration required.
Slightly curved blunt dissector, double-ended. Length 11 1/2" (272 mm)
Medicine Products: